A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis
Clinical trial NCT00484237 · COMPLETED
Trial details
- NCT number
- NCT00484237
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.